2-氨基-3-(2-氯苯基)丙酸盐酸盐 | 120108-63-6

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 苯丙氨酸类衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基-3-(2-氯苯基)丙酸盐酸盐
• 中文别名: 2-氯苯丙氨酸盐酸盐
• 英文名称: 2-amino-3-(2-chlorophenyl)propionic acid hydrochloride
• 英文别名: 2-chloro-phenylalanine ; hydrochloride；2-Chlor-phenylalanin; Hydrochlorid；2-amino-3-(2-chlorophenyl)propanoic acid hydrochloride；2-Chlorophenylalanine hydrochloride；2-amino-3-(2-chlorophenyl)propanoic acid;hydrochloride
• CAS: 120108-63-6
• 化学式: C₉H₁₀ClNO₂*ClH
• 分子量: 236.098
• InChiKey: JDVNKKKRAFSXTH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.72
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  63.3
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-氨基-3-(2-氯苯基)丙酸盐酸盐 在 potassium carbonate 、 三乙胺 作用下， 以 水 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 6.0h， 生成 7-chloro-3-(2-chlorobenzyl)-1-(4-methoxybenzyl)-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione
  参考文献：
  名称：

  [EN] BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME
  [FR] COMPOSÉS DE BENZODIAZÉPINONE ET MÉTHODES DE TRAITEMENT LES UTILISANT

  摘要：

  该发明提供了1,4-苯并二氮杂酮化合物、药物组合物以及治疗自身免疫性疾病、慢性炎症性疾病和过度增殖性疾病的方法。例如，这些1,4-苯并二氮杂酮化合物和药物组合物被认为对治疗类风湿关节炎、移植物抗宿主病、炎症性肠病等疾病有用。

  公开号：

  WO2011035124A1
• 作为产物：
  描述：

  N-acetyl-3-(2-chlorophenyl)-2-ethoxycarbonyl alanine ethyl ester 在 盐酸 作用下， 以 1,4-二氧六环 、 水 为溶剂， 以89%的产率得到2-氨基-3-(2-氯苯基)丙酸盐酸盐
  参考文献：
  名称：

  Anthranilic acid based CCK1 receptor antagonists: preliminary investigation on their second “touch point”

  摘要：

  In this phase of structure-affinity relationship study of VL-0395, a new anthranilic acid based CCK1 selective antagonist, we propose a series Of Unnatural aminoacidic derivatives. The result of this work is the identification of a new CCK ligand, which possesses an affinity (IC50 = 35 nm) one order of magnitude greater than the lead and, as a general rule, it points out how the hypothesized receptorial pocket which accommodates the Phe residue allows much more structural modification than that interacting with the N-terminal group. Hence, the modification of the C-terminal pharmacophoric group of our lead VL-0395 can not only enhance the affinity of anthranific acid derivatives but can modulate the selectivity for one CCK receptor subtype or afford mixed antagonists. (c) 2005 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2005.01.002

文献信息

• Compositions And Methods Relating To Novel Compounds And Targets Thereof
  申请人：Glick Gary D.

  公开号：US20080269194A1

  公开（公告）日：2008-10-30

  The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine compounds, and structurally and functionally related compounds, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, vascular abnormalities, and the like.

  本发明涉及新型化合物、其发现方法及其治疗用途。具体而言，本发明提供苯二氮平类化合物，以及结构和功能相关的化合物，并使用这些化合物作为治疗剂来治疗与编程细胞死亡、自身免疫、炎症、过度增殖、血管异常等过程的错误调节相关的多种疾病。
• Compositions and methods relating to novel compounds and targets thereof
  申请人：The Regents of the University of Michigan

  公开号：US07851465B2

  公开（公告）日：2010-12-14

  The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine compounds, and structurally and functionally related compounds, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, vascular abnormalities, and the like.

  本发明涉及新型化合物、其发现方法及其治疗用途。具体而言，本发明提供苯二氮平化合物和结构上和功能上相关的化合物，并提供使用这些化合物作为治疗剂治疗与程序性细胞死亡、自身免疫、炎症、过度增殖、血管异常等过程失调相关的多种疾病的方法。
• 1,4-BENZODIAZEPINONE COMPOUNDS AND THEIR USE IN TREATING CANCER
  申请人：Glick Gary D.

  公开号：US20120094982A1

  公开（公告）日：2012-04-19

  The invention provides a family of 1,4-benzodiazepinone compounds and methods for their use as therapeutic agents in treating cancer. Pharmaceutical compositions and methods of making the 1,4-benzodiazepinone compounds are provided.

  该发明提供了一系列1,4-苯二氮卓酮化合物及其在治疗癌症中作为治疗剂的使用方法。还提供了制备1,4-苯二氮卓酮化合物的药物组合物和方法。
• BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME
  申请人：Glick Gary D.

  公开号：US20120232067A1

  公开（公告）日：2012-09-13

  The invention provides 1,4-benzodiazepinone compounds, pharmaceutical compositions, and methods of treating autoimmune disorders, chronic inflammatory disorders, and hyperproliferative disorders. For example, the 1,4-benzodiazepinone compounds and pharmaceutical compositions are contemplated to be useful for treating rheumatoid arthritis, graft-versus-host disease, inflammatory bowel disease, and the like.

  本发明提供了1,4-苯二氮卓酮类化合物、制药组合物以及治疗自身免疫性疾病、慢性炎症性疾病和过度增生性疾病的方法。例如，考虑到1,4-苯二氮卓酮类化合物和制药组合物可用于治疗类风湿性关节炎、移植物抗宿主病、炎症性肠病等疾病。
• Benzodiazepinone compounds and methods of treatment using same
  申请人：Glick Gary D.

  公开号：US08673897B2

  公开（公告）日：2014-03-18

  The invention provides 1,4-benzodiazepinone compounds, pharmaceutical compositions, and methods of treating autoimmune disorders, chronic inflammatory disorders, and hyperproliferative disorders. For example, the 1,4-benzodiazepinone compounds and pharmaceutical compositions are contemplated to be useful for treating rheumatoid arthritis, graft-versus-host disease, inflammatory bowel disease, and the like.

  本发明提供了1,4-苯并二氮䓬酮类化合物、药物组合物以及治疗自身免疫性疾病、慢性炎症性疾病和过度增殖性疾病的方法。例如，本发明考虑使用1,4-苯并二氮䓬酮类化合物和药物组合物用于治疗类风湿性关节炎、移植物抗宿主病、炎症性肠病等疾病。